Vol. 279, Issue 3, H1383-H1391, September 2000
Polyamines decrease Ca2+ sensitivity of tension
and increase rates of activation in skinned cardiac myocytes
Samantha P.
Harris1,
Jitandrakumar R.
Patel1,
Laurence J.
Marton2,3,4, and
Richard L.
Moss1
Departments of 1 Physiology, 2 Pathology and
Laboratory Medicine, and 3 Oncology, University of Wisconsin
Medical School, Madison, 53706; and 4 SLIL Biomedical
Corporation, Madison, Wisconsin 53711
 |
ABSTRACT |
Owing
in part to their interactions with membrane proteins, polyamines (e.g.,
spermine, spermidine, and putrescine) have been identified as potential
modulators of membrane excitability and Ca2+ homeostasis in
cardiac myocytes. To investigate whether polyamines also affect cardiac
myofilament proteins, we assessed the effects of polyamines on
contractility using rat myocytes and trabeculae that had been
permeabilized with Triton X-100. Spermine, spermidine, and putrescine
reversibly increased the [Ca2+] required for half-maximal
tension (i.e., right-shifted tension pCa curves), with the following
order of efficacy: spermine (+4) > spermidine (+3) > putrescine (+2). However, synthetic analogs that differed from spermine
in charge distribution were not as effective as spermine in altering
isometric tension. None of the polyamines had a significant effect on
maximal tension, except at high concentrations. After flash photolysis
of DM-Nitrophen (a caged Ca2+ chelator), spermine
accelerated the rate of tension development at low and intermediate but
not high [Ca2+]. These results indicate that polyamines,
especially spermine, interact with myofilament proteins to reduce
apparent Ca2+ binding affinity and speed cross-bridge
cycling kinetics at submaximal [Ca2+].
spermine; cardiac muscle; myofilaments
 |
INTRODUCTION |
POLYAMINES
SUCH AS PUTRESCINE, spermidine, and spermine are biological
cations that are present in all mammalian cells. In these
cells, polyamines are an absolute requirement for normal cell growth
and division, and abnormal polyamine expression is associated with
tumorigenesis, altered gene expression, and induction of apoptotic
pathways (11). In the heart, aspects of both developmental and hypertrophic growth are associated with changes in polyamine metabolism, and it is known that induction of a rate-limiting enzyme in
their synthesis, ornithine decarboxylase (ODC), is among the first
responses to numerous hormonal and trophic stimuli (for review, see
Ref. 18). In some instances, such as hypertrophy induced by
-adrenergic agonists, inhibition of ODC attenuates cardiac growth
(2, 12).
Although the importance of polyamines to cell cycle and growth
regulation has been recognized for some time, the exact mechanisms by
which polyamines exert their effects are not yet fully understood. Owing in large part to their positive charge at neutral pH, the ability
of polyamines to bind to and stabilize nucleic acids and proteins is
thought to be essential for aspects of DNA, RNA, and protein function
(11). In addition, polyamines are known to bind with
varying affinity to a variety of cytoplasmic ligands including many
membrane proteins. The potential for these interactions to affect cell
cycle regulation has been suggested (44), as have
hypotheses that polyamines play more direct functional roles as
cytoplasmic modulators in various cell processes.
For cardiac and other excitable cell types, the hypothesis that
polyamines function as intracellular modulators has been strengthened by recent findings that polyamines, especially spermine, bind with high
affinity to several types of ion channels and affect their function
(for review, see Ref. 47). For instance, binding of polyamines to many
types of inward rectifier potassium channels (Kir channels)
results in a blocked channel state that gives rise to the anomalous
conductance properties of these channels (26, 25).
Furthermore, because Kir channels are the dominant means of
conductance at resting membrane potentials in myocardium, modulation of
their gating properties by changes in cytoplasmic polyamines has been
suggested as a mechanism whereby cell excitability and action potential
shape can be regulated (8, 30, 36).
Cell contractility may also be affected by polyamines. For example, in
isolated myocytes (45), strips of ventricular myocardium (5) and smooth muscle (31) exogenous
polyamines reduce cell contractility, presumably by blocking
Ca2+ channels and reducing intracellular
[Ca2+]. However, intracellular polyamines may
have opposite effects on cell contractility. For instance, in smooth
muscle that had been permeabilized to permit access to the cytosolic
compartment, polyamines potentiated contractile responses by increasing
myofilament Ca2+ sensitivity of tension (31,
39). These potentiating effects might be specific to smooth
muscle, however, because spermine and spermidine reduced MgATPase
activity and tension in glycerol-treated skeletal muscle (13,
14), and the effects of cytoplasmic polyamines on cardiac
myofilaments have not yet been investigated.
Therefore, in light of their potential to modulate membrane
excitability and contractility, the present study was undertaken to
investigate the effects of polyamines on cardiac myofilament proteins.
Detergent permeabilized ("skinned") myocytes and trabeculae were
used to allow access of polyamines to myofilaments and to minimize
potential interactions with membrane proteins and consequent effects on
intracellular Ca2+ handling. Results of the study show that
polyamines, particularly spermine, reduce myofilament Ca2+
sensitivity of tension and speed the kinetics of tension development through direct interactions with myofilament proteins. The results are
consistent with a role for cytoplasmic polyamines in contributing to
the overall contractile properties of cardiac muscle.
 |
MATERIALS AND METHODS |
Chemicals and solutions.
Chemicals, including HCl salts of putrescine, spermidine, and spermine,
were purchased from Sigma Chemical (St. Louis, MO), except
CaCl2 (Orion Research), propionic acid (Fluka), and
DM-Nitrophen (Calbiochem). Synthetic polyamine analogs were generously
provided by Benjamin Frydman of SLIL Biomedical (Madison, WI).
Relaxing and Ca2+-activating solutions for measurements of
Ca2+ sensitivity of force contained (in mmol/l) 20 imidazole, 7 EGTA, 4 MgATP, 5.4 MgCl2 (1 free
Mg2+), 14.5 creatine phosphate, and sufficient KCl to
adjust ionic strength to 180 mmol/l. In addition, relaxing and maximal
activating solutions contained CaCl2, such that free
Ca2+ concentration ([Ca2+]free)
was pCa 9.0 and 4.5, respectively, where pCa =
log
[Ca2+]. Solution pH was titrated with KOH to 7.0 at
15°C. A computer program (15) and published stability
constants (corrected for pH and temperature) (20) were
used to calculate the final concentrations of each metal, ligand, and
metal-ligand complex in solution. Solutions containing a range of
[Ca2+]free (i.e., pCa 6.2-5.2) were
prepared by mixing solutions of pCa 9.0 and pCa 4.5.
For measurement of rates of tension development, relaxing (pCa
9.0) and maximal activating (pCa 4.5) solutions were similar to those
described above except that 1) 100 mmol/l N,
N-bis[2-hydroxyethyl]-2-aminoethane sulfonic acid (BES)
was used in place of imidazole; 2) ionic strength was
adjusted with potassium propionate; and 3) 5 mmol/l
dithiothreitol (DTT) was added to each solution. The preactivating
solution contained (in mmol/l) 0.07 EGTA, 79 potassium propionate, 4.77 ATP, 5.29 MgCl2, 100 BES, 5 DTT, and 15 creatine phosphate.
Loading solution contained (in mmol/l) 1 DM-Nitrophen, 0.4 CaCl2, 75.2 potassium propionate, 4.77 ATP, 5.96 MgCl2, and 15 creatine phosphate. The apparent stability
constants for Ca2+-EGTA and Ca2+-DM-Nitrophen
were 2.39 × 106 M
1 and 2.0 × 108 M
1, respectively (22).
Preparation of ventricular myocytes and trabeculae.
Adult female Sprague-Dawley rats were anesthetized by inhalation of
methoxyflurane and their hearts were rapidly excised. Upon excision,
hearts were cannulated and mounted on a modified Langendorff apparatus
for retrograde perfusion via the coronary circulation. Ventricular
myocytes were obtained by enzymatic digestion of hearts as described
previously (37). Myocytes were skinned by incubation for 6 min at 22°C in relaxing solution containing (in mmol/l) 1.0 free
Mg2+, 100 KCl, 2.0 EGTA, 4.0 ATP, and 10 imidazole; and
0.03% Triton X-100. Skinned myocytes were washed twice in
detergent-free relaxing solution and stored on ice for use the same
day. For isolation of trabeculae, hearts were initially perfused with
an ice-cold cardioplegic solution containing (in mmol/l) 140 NaCl, 15 KCl, 1.2 MgCl2, 2.0 NaH2PO4, 5.0 sodium acetate, 10 HEPES, and 10 glucose, until perfusate exiting the
heart was visibly clear of blood. Hearts were then dissected and strips
(130-210 µm wide) of unbranched trabeculae, running between the
right ventricular free wall and tricuspid valve, were removed and
skinned for 30 min in a solution containing (in mmol/l) 58.2 potassium
proprionate, 7.0 EGTA, 4.75 ATP, 5.45 MgCl2, 0.02 CaCl2, 100 BES at pH 7.0, and 5 DTT; and 1% Triton X-100.
Ca2+ sensitivity of tension.
Ca2+ sensitivity of tension in skinned single myocytes was
determined as described previously (37). Myocytes were
placed in relaxing solution on the stage of an inverted microscope
(Zeiss), and a single myocyte was attached with silicone adhesive (Dow Corning) to two stainless steel pins. One pin was attached to the
active element of a force transducer (model 403, Cambridge Technology)
and the other to a length controller. The length controller was a
piezoelectric translator (Physik Instrumente) or, in some cases, a
torque motor (model 308B, Cambridge Technology). Both the force
transducer and the length controller were mounted on three-way
micromanipulators (Narishige) anchored to a vibration isolation table.
After the silicone adhesive was allowed to cure (~45 min), myocytes
were raised up off the stage and transferred to solution of pCa 9.0. Sarcomere length was adjusted to 2.3 µm using online video imaging.
Isometric tension was measured at 15°C by transferring the myocyte to
activating solutions containing a range of
[Ca2+]free and measuring the difference in
force just before and after a rapid slack step (~20% of cell
length). Ca2+-activated tension was determined as the
difference between isometric tension generated in activating solution
(pCa 6.1-4.5) and in relaxing solution (pCa 9.0). Isometric forces
(P) at submaximal pCa were expressed as a fraction of maximal force
(Po) measured at pCa 4.5, such that relative force
(PRel) = P/Po.
Effects of polyamines on tension were assessed after an initial 15-min
incubation of the myocyte in relaxing solution containing the desired
concentration of polyamine. Force measurements were then repeated with
polyamines in all activating and relaxing solutions. To assess
reversibility of polyamine effects, measurements were repeated
following three solution changes over a 10-min period using fresh
relaxing solution that lacked polyamines.
Rate of tension development.
The kinetics of force development were measured by recording the
increase in tension following flash photolysis of caged
Ca2+ from the chelator, DM-Nitrophen. Skinned trabeculae
were placed in a stainless steel experimental chamber and attached at
their ends to the arms of a length controller (model 350, Cambridge Technology) and force transducer (model 403, Cambridge Technology), as
previously described by Moss et al. (28). The chamber
assembly was then placed on the stage of an inverted microscope
(Olympus) fitted with a charge-coupled device camera. Light from a
halogen lamp was passed through a cutoff filter (
> 620 nm)
and then used to illuminate the preparation for video image analysis.
Sarcomere length was maintained at ~2.35 µm throughout the course
of an experiment.
Po measurements were performed by transferring each
trabecula from the relaxing solution to preactivating solution (2 min) and then to a maximally activating solution (pCa 4.5). Once tension reached a steady level, the preparation was rapidly slackened and
returned to relaxing solution. For measurements of the rate of tension
development, trabeculae were transferred from a preactivating solution
to a loading solution containing 1 mmol/l DM-Nitrophen and
CaCl2. At the end of a 5-min incubation in loading
solution, the trabeculae were transferred to an 80-µl quartz-walled
photolysis chamber filled with silicone oil (Dow Corning 200 fluid,
viscosity 10 cs). Rapid release of Ca2+ from DM-Nitrophen
was achieved using a flash of ultraviolet (UV) light (
= ~360 nm)
from a xenon lamp (Optoeletronik). After measurement of the postflash
active force (P), preparations were returned back to the relaxing
solution. Three cycles of loading and photolysis were randomly
performed to achieve low, intermediate, and high levels of postflash
force by photolyzing DM-Nitrophen with three different intensities of
UV light (generated by adjustment of the power supply to the UV flash
lamp). After measurements of postflash tension with DM-Nitrophen,
maximum force at pCa 4.5 was again determined to assess rundown of the preparation.
To examine the effects of spermine on the rate of force development,
preparations were incubated in the relaxing solution containing 1 mmol/l spermine for 15 min before repeating the above protocol. All
solutions, except maximum activating solutions, contained 1 mmol/l
spermine. Tension generated by each trabecula in the presence of
spermine was expressed relative to maximum tension (in pCa 4.5)
recorded immediately after the 15-min incubation in relaxing solution
containing spermine.
 |
RESULTS |
Effects of spermine on Ca2+ sensitivity of tension.
The Ca2+ sensitivity of tension of single ventricular
myocytes was determined by measuring developed isometric tension as a function of activating [Ca2+]. Figure
1 shows a comparison of normalized
tension-pCa relationships obtained from a single myocyte before
(control) and after inclusion of 1 mmol/l spermine in relaxing and
activating solutions. In the presence of spermine, the tension-pCa
relationship was shifted to the right relative to control and the pCa
at which force was half-maximal (pCa50) was decreased.
Summary data from five experiments (Table
1) showed that spermine significantly
reduced pCa50 values, indicating a reduction in the
apparent Ca2+ binding affinity of the
myofilament proteins by spermine. The steepness of the tension-pCa
curves was also somewhat increased in the presence of spermine as
indicated by an increase in Hill coefficients
(nH) (Table 1). Although the latter suggests
that the cooperativity of tension activation may be enhanced by
spermine, the result should be regarded as tentative due to the lack of robustness of the test statistics (power = 0.59). The effects of
spermine were readily reversed following a brief (10-15 min) washout period and elimination of spermine from activating and relaxing
solutions.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of spermine (SPM) on Ca2+ sensitivity
of isometric tension. Tension-pCa relationships obtained from a single
skinned myocyte were determined first in absence of SPM and then after
15-min incubation of the myocyte in relaxing solution containing 1 mmol/l SPM. For tension measurements in presence of SPM, 1 mmol/l SPM
was present in all activating and relaxing solutions. Tension-pCa
relationships were determined again after 15-min washout of SPM from
all solutions. Steady-state force (P) was expressed relative to maximum
steady-state force (Po) in solution of pCa 4.5. Smooth
lines were fit data in presence and absence of SPM using the Hill
equation:
where nH is the Hill coefficient and k
denotes the pCa at which relative force is half-maximal, i.e.,
pCa50. In absence of SPM, pCa50 was 5.67 and
was reduced to 5.49 in presence of 1 mmol/l SPM. pCa50
after washout of SPM was 5.66.
|
|
To investigate the concentration dependence of the shift in midpoint of
the tension-pCa relationship and to compare the effects of spermine,
spermidine, and putrescine on submaximal tension, the effects of
increasing polyamine concentration were assessed at a single submaximal
activating [Ca2+]. For each experiment, the pCa of the
activating solution was selected so that tension in the absence of
polyamines was close to 50% of maximum Ca2+-activated
tension, i.e., near the pCa50 for each myocyte. Figure 2A shows that addition of
spermine and spermidine to activating and relaxing solutions reduced
submaximal Ca2+-activated tension in a dose-dependent
manner. Spermine was more effective than spermidine, with significant
reductions in tension apparent at concentrations
400 µM. Putrescine
was the least effective, and reductions in tension were minimal even at
the highest concentration tested (6.4 mmol/l). Although low putrescine
concentrations (e.g., 200 µM) appeared to potentiate tension, the
effects were not statistically significant (P > 0.05).
Effects of polyamines on resting tension in relaxing solutions (pCa
9.0) were not observed.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of polyamines on submaximal tension in skinned
myocytes. For each experiment, an activating solution of pCa
5.6-5.8 was chosen to produce relative submaximal tension close to
50% of maximum Ca2+-activated tension (i.e., near
pCa50). Increasing concentrations of polyamines were then
added to relaxing and activating solutions and ~3 min after each
addition tension was again measured. After the tension measurement at
the highest polyamine concentration shown, myocytes were incubated in
fresh relaxing and activating solutions (lacking polyamines) and
tension was again measured (washout). Symbols represent the means ± SE of four or more experiments. A: effects of SPM,
spermidine, and putrescine on submaximal tension. B: effects
of bis(ethyl) synthetic polyamine analogs (BE-3-4-3 and
BE-4-4-4-4) on submaximal tension. SPM data as in
A were replotted for comparison. C: effects of
SPM in pCa solutions containing 1 mmol/l free Mg2+ and
either 4 mmol/l or 2 mmol/l MgATP.
|
|
At neutral pH, polyamines are protonated and carry net positive charge.
Spermine bears a net +4 valence, and spermidine and putrescine carry +3
and +2 charges, respectively. Because the relative efficacy of
polyamines at reducing tension was correlated with polyamine valence
(+4 > +3 > +2), the possibility that the effects of
spermine on tension were due primarily to counter-ion effects was
investigated by comparing the ability of synthetic polyamine analogs to
inhibit submaximal Ca2+-activated tension. As
shown in Fig. 2B, the bis-ethylated polyamine analogs,
N1,N12-bisethylspermine
(BE-3-4-3) (7) and
1,19,-bis-(ethylamino)-5,10,15-triazanondecane (BE-4-4-4-4) (4) bearing net +4 and +5
charges, respectively, were less effective than spermine at reducing
tension. The analogs differ from spermine in that they lack primary
amine groups and hence differ in their charge distribution. Therefore,
the ability of spermine to reduce Ca2+ sensitivity of
tension does not appear to depend entirely on the total charge of the
polyamine, and other structural properties are also likely to be
important. Consistent with this, polyamine charge distribution and
overall length have been shown to be relevant factors in determining
the specificity of polyamine interactions (3, 27).
Polyamines may also compete with Mg2+ for binding at
protein divalent cation binding sites and nucleotide phosphate moieties (29). Because all solutions used here contained 1 mmol/l
calculated free Mg2+ and 4 mmol/l MgATP, experiments were
done to test the possibility that the effects of spermine to reduce
submaximal tension depend on concentrations of these constituents.
Figure 2C shows the effects of spermine on myocte tension in
solutions containing 1 mmol/l free Mg2+ and 2 mmol/l MgATP.
When [MgATP] was reduced, the effect of spermine to inhibit tension
was increased relative to its effects in solutions containing 4 mmol/l
MgATP. This result is consistent with spermine binding to ATP phosphate
moieties and suggests that polyamines added to myocyte bath solutions
are effectively buffered by ATP. Thus the polyamine concentration
required to elicit contractile effects is likely to be an overestimate
relative to the concentration required in ATP-free solutions. Also, the
finding that spermine had greater effects when MgATP was reduced
suggests that a secondary increase in Mg2+ is not the
primary mechanism by which spermine reduces tension.
Effects of spermine on maximum Ca2+-activated tension.
To determine whether polyamine-induced reductions in tension were
related to decreases in the force-generating capabilities of myosin
cross bridges (e.g., the number of cross bridges or the force per cross
bridge), effects of spermine on maximum Ca2+-activated
tension (Po) were investigated. A single concentration of
spermine was tested in each myocyte by first activating in a pCa 4.5 solution in the absence of spermine and again after the addition of
spermine to relaxing and activating solutions. A final tension
measurement was made following washout of spermine from all solutions.
As shown in Fig. 3, spermine
significantly reduced maximum tension at concentrations
3.2 mmol/l.
Effects of spermine were reversed upon removal of spermine from
relaxing and activating solutions.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of SPM on maximum Ca2+-activated
tension. Maximum Ca2+-activated tension (pCa 4.5) was
measured in absence and presence of SPM and again after 15-min washout
of SPM from solutions. Tension in presence of SPM and after washout was
expressed relative to initial maximum tension measurement in absence of
SPM. Bars represent means ± SE of three or more experiments.
*Significantly different from control (0 mmol/l SPM). P < 0.05, one-way ANOVA.
|
|
Figure 4 shows cumulative effects of
spermine, spermidine, and putrescine on maximum tension. Similar to
effects on submaximal tension, the order of efficacy for reducing
maximum tension was spermine > spermidine > putrescine.
However, in contrast to effects on submaximal tension, reductions in
tension by spermine (+4) at saturating [Ca2+] were not
different from those of the synthetic spermine analog BE 3-4-3
(+4) (data not shown). These data suggest that at maximal activation,
the effects of spermine to inhibit tension are relatively nonspecific,
related more to total polyamine valence than to other structural
characteristics.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 4.
Cumulative effects of polyamines on maximum
Ca2+-activated tension. For each experiment, maximum
Ca2+-activated isometric tension was initially measured in
solution of pCa 4.5. Increasing concentrations of polyamines were then
added to relaxing (pCa 9.0) and activating solutions and tension
measurements were repeated. After the tension measurement at the
highest polyamine concentration shown, myocytes were incubated in fresh
relaxing and activating solutions (without polyamines) and tension was
again measured (washout). Symbols represent means ± SE of four or
more experiments. SPD, spermidine; PUT, putrescine.
|
|
Effects of spermine on kinetics of tension development.
Alterations in myofilament Ca2+ sensitivity of tension have
been related to changes in one or more of three variables:
1) the Ca2+ binding affinity of the thin
filament protein troponin C (TnC); 2) cooperative
interactions among myofilament proteins; and 3) the rate of
cross-bridge cycling. Because the slope of the pCa-tension relationship, which provides an index of apparent cooperativity among
the contractile proteins, was only modestly affected by spermine (Table
1), it seemed unlikely that reductions in Ca2+ sensitivity
were due primarily to changes in cooperative activation by spermine. To
distinguish between the remaining possibilities, we measured the rate
constant of tension development (kCa) following rapid release of Ca2+ from a photolabile
Ca2+ chelator, DM-Nitrophen
(32). This measurement is analogous to the rate constant
of tension redevelopment (ktr) following a
release and restretch maneuver and has been interpreted as a net
rate constant describing cross-bridge cycling kinetics
(9).
The effects of 1 mmol/l spermine on the tension development in a
skinned trabecula following flash photolysis of DM-Nitrophen are shown
in Fig. 5. Before photolysis of
DM-Nitrophen, trabeculae generated no measurable tension in a loading
solution containing 0.4 mmol/l Ca2+ buffered with 1 mmol/l
DM-Nitrophen (calculated free Ca2+, pCa 5.85). After flash
photolysis of DM-Nitrophen, trabeculae developed tension that was
proportional to the intensity of the UV flash. Under control conditions
(Fig. 5A), photolysis with low, intermediate, and high
levels of UV light resulted in steady isometric tensions of 0.41, 0.70, and 0.92 Po. Figure 5B shows the same data
normalized to the peak tension after flash. The half-times of tension
development were 146, 114, and 76 ms, respectively. These data indicate
that the rate of tension development increased with
[Ca2+], in agreement with previous reports of the
Ca2+ dependence of the rate of force development in intact
(1) and skinned myocardium (17, 48).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of SPM on isometric tension and rate of tension development
in skinned cardiac trabeculae. A: skinned trabeculae were
incubated in loading solution (0.4 mmol/l CaCl2 and 1 mmol/l DM-Nitrophen, calculated free [Ca2+] = pCa 5.85)
for 3 min, transferred to silicone oil in a quartz trough, and then
exposed to a low- (c, 150 V), intermediate- (b,
200 V), or high- (a, 350 V) intensity ultraviolet (UV) light
flash (F) to achieve variable release of Ca2+.
Tension was recorded and trabeculae were then returned to relaxing
solution. Three separate tension traces from the same trabecula are
shown and are expressed relative to tension generated in solution of
pCa 4.5. B: data in A were normalized to the peak
tension generated at each flash intensity (a, b,
and c). C and D: tension traces
recorded from the same trabecula in the presence of 1 mmol/l SPM. The
trabecula was incubated for 15 min in a relaxing solution containing 1 mmol/l SPM, and tension measurements were done as described in
A. All solutions, except pCa 4.5, contained 1 mmol/l SPM.
|
|
Similar measurements repeated in the presence of 1 mmol/l spermine
resulted in steady tensions of 0.34, 0.56, and 0.77 Po in
response to the same low-, intermediate-, and high-intensity UV flashes
(Fig. 5C). Thus consistent with the steady-state
measurements in single skinned myocytes, 1 mmol/l spermine reduced
tension at each submaximal [Ca2+]. However, as shown in
Fig. 5D, the half-times to peak tension following low- and
intermediate-intensity but not high-intensity flashes were decreased in
the presence of spermine (116, 104, and 74 ms, respectively).
Summary data obtained in the absence and presence of 1 mmol/l spermine
are shown for five trabeculae in Fig. 6.
Half-time to peak tension is plotted versus tension amplitude,
expressed relative to maximum tension (Po) in the same
preparations, following photolysis with low-, intermediate-, and
high-intensity flashes. Comparison of the two curves indicates that
spermine shifted the Ca2+ dependence of the activation
kinetics such that rate of tension development was sped (decreased
half-time to peak tension) at low and intermediate levels of
Ca2+. At high-flash intensity (high [Ca2+]),
rates were similar in the presence and absence of spermine. Thus
spermine alters the Ca2+ dependence of the tension
development rate without affecting the maximum rate of tension
development.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Summary data of the effects of SPM on tension and rate
constant of tension development in skinned cardiac trabeculae. Relative
tension following flash photolysis of DM-Nitrophen with low,
intermediate, and high intensities of UV light were plotted against
half-time to peak tension. The means ± SE of 5 trabeculae in the
absence ( ) and presence ( ) of 1 mmol/l SPM are
shown.
|
|
 |
DISCUSSION |
The primary determinants of the force and speed of contraction in
intact myocardium are the amplitude and duration of the intracellular
Ca2+ transient, the responsiveness of the myofilaments to
Ca2+, and the intrinsic cycling kinetics of the contractile
proteins. Previous studies suggested that cell excitability (23,
25) and Ca2+ delivery (45) might be
influenced by polyamines. Results of the present study, done with
detergent-permeabilized myocytes to allow control of
[Ca2+] in solutions bathing the myofilaments, provide the
first evidence that polyamines can affect cardiac contractility through
direct effects on myofilament proteins. In the presence of polyamines, the Ca2+ sensitivity of tension is decreased and
cross-bridge cycling kinetics are increased.
Mechanisms of polyamine effects.
A decrease in the apparent Ca2+ binding affinity of the
myofilaments could result from a direct competitive effect of spermine to reduce Ca2+ binding by the thin-filament regulatory
protein TnC. Because Ca2+ binding by TnC was not directly
measured in the present study, this possibility cannot be eliminated.
However, observations that spermine produced differential effects on
tension and the rate constants of tension development
(kCa) suggest that other mechanisms in addition
to or in place of effects on TnC are involved. For example, in skinned
skeletal muscle fibers calmidazolium increases TnC-Ca2+
binding affinity resulting in increases of both isometric force and the
rate of tension development (i.e., ktr)
(34). Therefore, it seems unlikely that a reduction in
TnC-Ca2+ binding by spermine could itself account for both
the decreased Ca2+ sensitivity of tension and
increased rates of tension development.
On the other hand, the effect of spermine to increase
kCa at submaximal [Ca2+] is
indicative of increased cross-bridge cycling kinetics. Because binding
of Ca2+ to TnC is thought to be rapid relative to the rates
of cross-bridge attachment and detachment, measurements of the rate of
tension development (e.g., kCa and
ktr) have previously been interpreted in terms
of the apparent rate constants limiting cross-bridge transitions to and
from attached, force-generating states (9). According to a
two-state model, with one attached and one detached state (e.g., 9),
kCa is equivalent to the sum of the apparent forward (fapp) and reverse
(gapp) rate constants. Thus the current observations that kCa is increased at submaximal
Ca2+ is compatible with effects of spermine to either
increase the rate of cross-bridge attachment or the rate of detachment.
However, because steady-state force is proportional to
fapp/(fapp + gapp), an increase in
gapp, the rate of cross-bridge
detachment, most easily accounts for the simultaneous decrease in force
and increase in rate of tension development. Further experiments are
necessary to test this hypothesis.
Other explanations for the differential effects of polyamines on
tension and rate of tension development are also possible. For
instance, kinetic schemes that incorporate additional cross-bridge states (35) or that include cooperative interactions that
act to promote thin filament activation (10) may be
necessary to describe the dual effects of spermine on steady-state
tension and rate of tension development. For example, additional
strongly bound, non-force-generating cross-bridge states were used to
describe the opposing effects of caffeine (46) and
Pi (35) on tension and cross-bridge cycling
kinetics. Of potential relevance, spermine is known to bind phosphate
moieties with high affinity (29). By stabilizing a
phosphate-bound, cross-bridge state, spermine could potentially
influence cross-bridge transitions and thereby mimic the ability of
Pi to reduce tension and accelerate cycling kinetics.
Muscle-type specificity of polyamine effects. The contractile effects
reported here for polyamines in cardiac muscle differ from those in
smooth muscle and may reflect tissue-specific differences between
muscle types. For instance, at concentrations comparable to those used
here, polyamines increase myofilament Ca2+ sensitivity in
mildly permeabilized smooth muscle cells (31, 38).
However, the effects observed in smooth muscle result primarily from
inhibition of myosin phosphatase activity, resulting in increased phosphorylation of myosin regulatory light chains (RLCs)
(40). Although not directly assessed in the current study,
increased RLC phosphorylation in cardiac cells is also associated with
force potentiation (16). Therefore, it seems unlikely that
the effects of polyamines in heart cells are mediated through analogous
mechanisms. Furthermore, the more extensive permeabilization of the
cardiac myocytes with Triton X-100 and the ability to rapidly wash out the effects of polyamines argues against changes in the phosphorylation state of myofilament proteins as a primary mechanism by which the
polyamine effects are mediated. Thus the effects of polyamines observed
in the current study apparently occur independent of changes in
phosphorylation state and are due instead to direct interactions with
myofilament proteins.
Direct stimulatory effects of polyamines have been observed in smooth
muscle in the absence of changes in RLC phosphorylation (38,
42). The mechanism of these effects is potentially related to
the ability of poly-L-lysine, a polycationic peptide, to
promote the transition of myosin from a globular (10S) conformation to a filamentous (6S) form (41). Because myosin from striated
muscle does not undergo such conformational changes upon activation, these effects may also be specific to smooth muscle. However, because
the molecular basis for direct polyamine effects have not been
identified for either smooth or cardiac muscle, it is possible that the
sites of interaction are similar.
In contrast to smooth muscle, the effects of polyamines in cardiac
cells are similar to effects observed in skeletal muscle. For instance,
in glycerin-treated skeletal muscle, polyamines reduced tension and
MgATPase activity (13, 14). In addition, in skinned psoas
fibers, steady-state tension was reduced and activation kinetics at
submaximal [Ca2+] were sped by 1 mmol/l spermine (S. P. Harris, J. R. Patel, L. J. Marton, and R. L. Moss,
unpublished observations). These data suggest that the contractile
effects of polyamines are similar in cardiac and fast skeletal fibers
and therefore may be common to all striated muscle.
Physiological implications.
On the basis of observations that the Ca2+ sensitivity of
tension differs between intact and skinned cardiac trabeculae, Gao et
al. (19) proposed the existence of soluble
Ca2+ sensitizers that contribute to the inotropic
properties of cardiac muscle. Although the effects of polyamines to
reduce steady-state Ca2+ sensitivity in skinned myocytes
would seem to preclude a role in Ca2+ sensitization, the
effects of spermine reported here occur at concentrations compatible
with values of total polyamine content in heart and so may influence
overall contractile status. For example, a survey of mouse striated
muscles showed that polyamine concentrations were related to muscle
type and were highest in cardiac muscle (24). Among the
different polyamines, the concentration of spermine was greatest, i.e.,
440 nmol/g, a value in close agreement to frequently reported values
for polyamine content of rat heart (200-400 nmol/g) (21,
33).
Moreover, polyamine synthetic enzymes are highly inducible and the
cellular content of all three polyamines can be elevated severalfold in
response to a variety of inotropic stimuli, including
-adrenergic
agonists (18). Such changes in polyamine content could
potentially affect cell contractility through interactions with
myofilament proteins as described here. For example, the effects of
-adrenergic stimulation are qualitatively similar to those induced
by spermine (37). Polyamine interactions with myofilament
proteins may thereby contribute to or modulate inotropic responsiveness. Consistent with this, metabolic inhibition of polyamine
synthesis in rats produced reductions of cardiac putrescine and
spermidine levels that were associated with decreased inotropic responsiveness to ouabain, norepinephrine, and Ca2+ in
vitro (6). Thus despite uncertainties regarding the
concentrations of free cytoplasmic polyamines and their subcellular
distributions (11, 43), basal or stimulated cardiac
inotropic state may be affected through polyamine interactions with
myofilament proteins as described here.
 |
ACKNOWLEDGEMENTS |
The authors thank Dr. Benjamin Frydman for the generous gift of
synthetic polyamine analogs.
 |
FOOTNOTES |
This work was supported by National Institutes of Health Grant 47053 (to R. L. Moss) and was done during the tenure of a postdoctoral fellowship (to S. P. Harris) from the American Heart Association, Northland Affiliate.
Address for reprint requests and other correspondence: S. P. Harris, 109 SMI, 1300 University Ave., Madison, WI 53706 (E-mail: spharris{at}facstaff.wisc.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 2 December 1999; accepted in final form 15 March 2000.
 |
REFERENCES |
1.
Baker, AJ,
Figueredo VM,
Keung EC,
and
Camacho SA.
Ca2+ regulates the kinetics of tension development in intact cardiac muscle.
Am J Physiol Heart Circ Physiol
275:
H744-H750,
1998[Abstract/Free Full Text].
2.
Bartolome, J,
Huguenard J,
and
Slotkin TA.
Role of ornithine decarboxylase in cardiac growth and hypertrophy.
Science
210:
793-794,
1980[Abstract/Free Full Text].
3.
Basu, HS,
Marton LJ,
Pellarin M,
Deen DF,
McManis JS,
Liu CZ,
Bergeron RJ,
and
Feuerstein BG.
Design and testing of novel cytotoxic polyamine analogs.
Cancer Res
54:
6210-6214,
1994[Abstract/Free Full Text].
4.
Basu, HS,
Pellarin M,
Feuerstein BG,
Shirahata A,
Samejima K,
Deen DF,
and
Marton LJ.
Interaction of polyamine analogue, 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines.
Cancer Res
53:
3948-3955,
1993[Abstract/Free Full Text].
5.
Bazzani, C,
Genedani S,
and
Bertolini A.
Effect of polyamines on perfused rat heart contractility.
Pharmacol Res Commun
17:
873-881,
1985[Web of Science][Medline].
6.
Bazzani, C,
Genedani S,
Tagliavani S,
Piccinini G,
and
Bertolini A.
Treatment with polyamine synthesis inhibitors reduces the positive inotropic effect of ouabain, noradrenaline, and calcium.
Pharmacol Res Commun
20:
23-35,
1988[Web of Science][Medline].
7.
Bergeron, RJ,
Neims AH,
McManis JS,
Hawthorne TR,
Vinson JRT,
Bortell R,
and
Ingeno MJ.
Synthetic polyamine analogues as antineoplastics.
J Med Chem
31:
1183-1190,
1988[Web of Science][Medline].
8.
Bianchi, L,
Roy ML,
Taglialatela M,
Lundgren DW,
Brown AM,
and
Ficker E.
Regulation by spermine of native inward rectifier K+ channels in RBL-1 cells.
J Biol Chem
271:
6114-6121,
1996[Abstract/Free Full Text].
9.
Brenner, B.
Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle.
Proc Natl Acad Sci USA
85:
3265-3269,
1988[Abstract/Free Full Text].
10.
Campbell, K.
Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics.
Biophys J
72:
254-262,
1997[Web of Science][Medline].
11.
Cohen, SS.
A Guide to the Polyamines. New York: Oxford University Press, 1998.
12.
Cubria, JC,
Reguera R,
Balana-Fouce R,
Ordonez C,
and
Ordonez D.
Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse.
J Pharm Pharmacol
50:
91-96,
1998[Web of Science][Medline].
13.
De Meis, L.
Relaxing effect of spermine and spermidine on intact and glycerol-treated muscle.
Am J Physiol
212:
92-96,
1967.
14.
De Meis, L,
and
De Paula HJ.
Polyamines and muscle relaxation: inhibition of actomyosin ATPase activity by spermine and spermidine.
Arch Biochem Biophys
119:
16-21,
1967[Web of Science][Medline].
15.
Fabiato, A.
Computer programs for calculating total from specified free and free from specified total ionic concentrations in aqueous solutions containing multiple metals or ligands.
Methods Enzymol
157:
378-417,
1988[Web of Science][Medline].
16.
Fitzsimons, DP,
Bodell PW,
and
Baldwin KM.
Myocardial functional correlates of cardiac myosin light chain 2 phosphorylation.
J Appl Physiol
68:
2426-2433,
1990[Abstract/Free Full Text].
17.
Fitzsimons, DP,
Patel JR,
and
Moss RL.
Role of myosin heavy chain composition in kinetics of force development and relaxation in rat myocardium.
J Physiol (Lond)
513:
171-183,
1998[Abstract/Free Full Text].
18.
Flamigni, F,
Rossoni C,
Stefanelli C,
and
Caldarera CM.
Polyamine metabolism and function in the heart.
J Mol Cell Cardiol
18:
3-11,
1986[Web of Science][Medline].
19.
Gao, WD,
Backx PH,
Azan-Backx M,
and
Marban E.
Myofilament Ca2+ sensitivity in intact versus skinned rat ventricular muscle.
Circ Res
74:
408-415,
1994[Abstract/Free Full Text].
20.
Godt, RE,
and
Lindley BD.
Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of the frog.
J Gen Physiol
80:
279-297,
1982[Abstract/Free Full Text].
21.
Hasegawa, S,
Nakano M,
Hamana K,
Taniguchi Y,
Iwasaki T,
Kanda T,
Suzuki T,
and
Nagai R.
Decrease in myocardial polyamine concentration in rats with myocardial infarction.
Life Sci
60:
1643-1650,
1997[Web of Science][Medline].
22.
Kaplan, JH,
and
Ellis-Davies GCR
Photolabile chelators for the rapid photorelease of divalent cations.
Proc Natl Acad Sci USA
85:
6571-6575,
1988[Abstract/Free Full Text].
23.
Kecskemeti, V,
Kelemen K,
Marko R,
and
Selmeci L.
Modification of cardiac transmembrane potentials and currents by polyamines.
Eur J Pharmacol
142:
297-303,
1987[Web of Science][Medline].
24.
Kremzner, LT,
Tennyson VM,
and
Miranda AF.
Polyamine metabolism in normal, denervated, and dystrophic muscle.
In: Advances in Polyamine Research, edited by Campbell RA,
Morris DR,
and Bartos D. GD. New York: Raven, 1978, p. 241-256.
25.
Lopatin, AN,
Makhina EN,
and
Nichols CG.
Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification.
Nature
372:
366-369,
1994[Medline].
26.
Lopatin, AN,
Makhina EN,
and
Nichols CG.
The mechanism of inward rectification of potassium channels: "long pore plugging" by cytoplasmic polyamines.
J Gen Physiol
106:
923-955,
1995[Abstract/Free Full Text].
27.
McCormack, SA,
Zimmerman BJ,
Israel M,
Blanner P,
and
Johnson LR.
Structural requirements of analogues of polyamines for migration and growth of IEC-6 cells.
Mol Pharmacol
48:
724-729,
1995[Abstract].
28.
Moss, RL,
Giulian GG,
and
Greaser ML.
Effects of EDTA treatment upon the subunit composition and mechanical properties of mammalian single skeletal fibers.
J Cell Biol
96:
970-978,
1983[Abstract/Free Full Text].
29.
Nakai, C,
and
Glinsmann W.
Interactions between polyamines and nucleotides.
Biochemistry
16:
5636-5641,
1977[Medline].
30.
Nichols, CG,
Makhina EN,
Pearson WL,
Sha Q,
and
Lopatin AN.
Inward rectification and implications for cardiac excitability.
Circ Res
78:
1-7,
1996[Abstract/Free Full Text].
31.
Nilsson, B-O,
Gomez M,
Santiago Carrilho R,
Nordstrom I,
and
Hellstrand P.
Differential actions of exogenous and intracellular spermine on contractile activity in smooth muscle of rat portal vein.
Acta Physiol Scand
154:
355-365,
1995[Web of Science][Medline].
32.
Patel, JR,
Diffee GM,
and
Moss RL.
Myosin regulatory light chain modulates the Ca2+ dependence of the kinetics of tension development in skeletal muscle fibers.
Biophys J
70:
2333-2340,
1996[Web of Science][Medline].
33.
Pegg, AE.
Effect of
-difluoromethylornithine on cardiac polyamine content and hypertrophy.
J Mol Cell Cardiol
13:
881-887,
1981[Web of Science][Medline].
34.
Regnier, M,
Martyn DA,
and
Chase PB.
Calmidazolium alters Ca2+ regulation of tension redevelopment rate in skinned skeletal muscle.
Biophys J
71:
2786-2794,
1996[Web of Science][Medline].
35.
Regnier, M,
Morris C,
and
Homsher E.
Regulation of the cross-bridge transition from a weakly bound state in skinned rabbit muscle fibers.
Am J Physiol Cell Physiol
269:
C1532-C1539,
1995[Abstract/Free Full Text].
36.
Shyng, S-L,
Sha Q,
Ferrigni T,
Lopatin AN,
and
Nichols CG.
Depletion of intracellular polyamines relieves inward rectification of potassium channels.
Proc Natl Acad Sci USA
93:
12014-12019,
1996[Abstract/Free Full Text].
37.
Strang, KT,
Sweitzer NK,
Greaser ML,
and
Moss RL.
-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats.
Circ Res
74:
542-549,
1994[Abstract/Free Full Text].
38.
Sward, K,
Dreja K,
and
Hellstrand P.
Contractile effects of polycations in permeabilized smooth muscle.
J Muscle Res Cell Motil
19:
463-472,
1998[Web of Science][Medline].
39.
Sward, K,
Nilsson B-O,
and
Hellstrand P.
Inhibition of polyamine synthesis influences contractility of intestinal smooth muscle in culture.
Am J Physiol Cell Physiol
273:
C77-C84,
1997[Abstract/Free Full Text].
40.
Sward, K,
Pato MD,
Nilsson B-O,
Nordstrom I,
and
Hellstrand P.
Polyamines inhibit myosin phosphatase and increase LC20 phosphorylation and force in smooth muscle.
Am J Physiol Cell Physiol
269:
C563-C571,
1995[Abstract/Free Full Text].
41.
Szymanski, P,
Ferguson DG,
and
Paul RJ.
Polylysine activates smooth muscle myosin ATPase activity via induction of a 10S to 6S transition.
Am J Physiol Cell Physiol
265:
C379-C386,
1993[Abstract/Free Full Text].
42.
Szymanski, PW,
Strauss JD,
Doerman G,
DiSalvo J,
and
Paul RJ.
Polylysine activates smooth muscle actin-myosin interaction without LC20 phosphorylation.
Am J Physiol Cell Physiol
262:
C1446-C1455,
1992[Abstract/Free Full Text].
43.
Tabor, CW,
and
Tabor H.
Polyamines.
Annu Rev Biochem
53:
749-790,
1984[Web of Science][Medline].
44.
Taglialatela, M,
Ficker E,
Wible B,
and
Brown AM.
Pharmacological implications of inward rectifier K+ channels regulation by cytoplasmic polyamines.
Pharmacol Res
32:
335-344,
1995[Web of Science][Medline].
45.
Ventura, C,
Ferroni C,
Flamigni F,
Stefanelli C,
and
Capogrossi MC.
Polyamine effects on [Ca2+]i homeostasis and contractility in isolated rat ventricular cardiomyocytes.
Am J Physiol Heart Circ Physiol
267:
H587-H592,
1994[Abstract/Free Full Text].
46.
Wahr, PA,
and
Metzger JM.
Role of Ca2+ and cross bridges in skeletal muscle thin filament activation probed with Ca2+ sensitizers.
Biophys J
76:
2166-2176,
1999[Web of Science][Medline].
47.
Williams, K.
Interactions of polyamines with ion channels.
Biochem J
325:
289-297,
1997.
48.
Wolff, MR,
McDonald KS,
and
Moss RL.
Rate of tension development in cardiac muscle varies with level of activator calcium.
Circ Res
76:
154-160,
1995[Abstract/Free Full Text].
Am J Physiol Heart Circ Physiol 279(3):H1383-H1391
0363-6135/00 $5.00
Copyright © 2000 the American Physiological Society